Evaluation of contrast-enhanced ultrasound of the pancreas combined with concurrent hormone stimulation

Ultraschall in der Medizin

Volumn 29, Issue 5, 2008, Pages 520-524

  Grossjohann, Hanne Soender ^a,b   Bachmann Nielsen, M ^a   Nielsen, K R ^a   Hansen, C P ^a   Svendsen, L B ^a   Stadil, F ^a  

^a Rigshospitalet

^b Mental Health Services CPH   (Denmark)

Author keywords

CCK 8s; Contrast agents; Pancreas; Secretin; Ultrasound

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; SECRETIN;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HORMONE RELEASE; INTERMETHOD COMPARISON; LAPAROTOMY; NONHUMAN; PANCREAS; SWINE; ULTRASOUND;

ANIMALS; BLOOD FLOW VELOCITY; CONTRAST MEDIA; IMAGE ENHANCEMENT; LAPAROTOMY; PANCREAS; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 54849434642     PISSN: 01724614     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963292     Document Type: Article

References (18)

1. Sofuni A, Iijima H, Moriyasu F et al. Differential diagnosis of pancretic tumors using ultrasound contrast agent. J Gastroenterol 2005; 40: 518-525
2. Kitano M, Kudo M, Maekawa K et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut 2004; 53: 854-859
3. Nagase M, Furuse J, Ishii H et al. Evaluation of contrast enhancement pattern in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent. J Ultrasound Med 2003; 22: 789-795
4. Takeda K, Goto H, Hirooka Y et al. Contrast-enhanced transabdominal ultrasonography in the diagnosis of pancreatic mass lesions. Acta Radiol 2003; 44: 103-106
5. Lankisch PG. Pancreatic function tests. Gut 1982; 23: 777-798
6. Moriyoshi Y, Shiratori K, Watanabe S et al. Potentiating effect of CCK and secretin on rat exocrine pancreas and its cholinergic dependence. Pancreas 1991; 6: 603-608
7. Schneider M. Charateristics of SonoVuetrade mark. Echocardiography 1999; 16: 743-746
8. Li J, Dong BW, Yu XL et al. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study. J Ultrasound Med 2005; 24: 975-983
9. Skjoldbye B, Pedersen MH, Struckmann J et al. Improved detection and biopsy of solid lesions using pulse-inversion ultrasound scanning and contrast agent infusion. Ultrasound Med Biol 2002; 28: 439-444
10. Grossjohann HS, Nielsen MB. Ultrasound contrast agents may help in avoiding necrotic areas at biopsy. Ultraschall in Med 2006; 27: 2-3
11. D'Onofrio M, Malago R, Zamboni G et al. Contrast-enhanced ultrasonography better identifies pancreatic tumor vascularization than helical CT. Pancreatology 2005; 5: 398-402
12. Itoh T, Hirooka Y, Itoh A et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005; 1: 144-152
13. Sener SF, Fremgen A, Menck HR et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg 1999; 189: 129-130
14. Nielsen MB, Bang N. Contrast enhanced ultrasound in liver imaging. Eur J Radiol 2004; 51 s Suppl: 3-8
15. Dietrich CF. Characterisation of focal liver lesions with contrast enhanced ultrasonography. Eur J Radiol 2004; 51 s Suppl: 9-17
16. Strobel D, Krodel U, Martus P et al. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors. J Clin Ultrasound 2000; 28: 1-13
17. Youk JH, Kim CS, Lee JM. Contrast-enhanced agent detection imaging: value in the characterization of focal hepatic lesions. J Ultrasound Med 2003; 22: 897-910
18. Bleuzen A, Huang C, Olar M et al. Diagnostic Accuracy of contrast-enhanced ultrasound in focal lesions of the liver using Cadence Contrast Pulse Sequencing. Ultraschall in Med 2006; 27: 40-48